UAP1L1
UDP-N-acetylhexosamine pyrophosphorylase-like protein 1
Also known as: UAP1L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3KQV9
- Gene
- UAP1L1
- Ensembl
- ENSG00000197355
- Chromosome
- 9
- Canonical length
- 507 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Intermediate filaments,Cytosol
OverviewNCBI Gene
Predicted to enable UDP-N-acetylglucosamine diphosphorylase activity. Predicted to be involved in UDP-N-acetylglucosamine biosynthetic process. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
507 residues, UniProt reviewed canonical sequence.
>Q3KQV9|UAP1L1
1 MASEQDVRAR LQRAGQEHLL RFWAELAPEP RAALLAELAL LEPEALREHC RRAAEACARP
61 HGPPPDLAAR LRPLPPERVG RASRSDPETR RRWEEEGFRQ ISLNKVAVLL LAGGQGTRLG
121 VTYPKGMYRV GLPSRKTLYQ LQAERIRRVE QLAGERHGTR CTVPWYVMTS EFTLGPTAEF
181 FREHNFFHLD PANVVMFEQR LLPAVTFDGK VILERKDKVA MAPDGNGGLY CALEDHKILE
241 DMERRGVEFV HVYCVDNILV RLADPVFIGF CVLQGADCGA KVVEKAYPEE PVGVVCQVDG
301 VPQVVEYSEI SPETAQLRAS DGSLLYNAGN ICNHFFTRGF LKAVTREFEP LLKPHVAVKK
361 VPYVDEEGNL VKPLKPNGIK MEKFVFDVFR FAKNFAALEV LREEEFSPLK NAEPADRDSP
421 RTARQALLTQ HYRWALRAGA RFLDAHGAWL PELPSLPPNG DPPAICEISP LVSYSGEGLE
481 VYLQGREFQS PLILDEDQAR EPQLQESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UAP1L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- spleen: 21 nTPM
- pituitary gland: 15 nTPM
- spinal cord: 14 nTPM
- adrenal gland: 14 nTPM
- kidney: 14 nTPM
- thyroid gland: 14 nTPM
Single-cell type
- hofbauer cells: 32 nCPM
- astrocytes: 25 nCPM
- oligodendrocytes: 23 nCPM
- retinal pigment epithelial cells: 21 nCPM
- choroid plexus epithelial cells: 19 nCPM
- retinal ganglion cells: 19 nCPM
Immune cell
- classical monocyte: 1 nTPM
- MAIT T-cell: 0.8 nTPM
- intermediate monocyte: 0.5 nTPM
- memory B-cell: 0.5 nTPM
- myeloid DC: 0.5 nTPM
- T-reg: 0.5 nTPM
Brain region
- white matter: 35 nTPM
- thalamus: 24 nTPM
- basal ganglia: 24 nTPM
- cerebral cortex: 23 nTPM
- medulla oblongata: 20 nTPM
- choroid plexus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UAP1L1 as an antibody target. Whether an autoantibody or antibody against UAP1L1 could matter depends on whether native UAP1L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UAP1L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UAP1L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...